FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals Limited's supplemental application for desvenlafaxine succinate (desvenlafaxine) under ANDA204003.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)